orserdu
stemline therapeutics b.v. - elacestrant - neoplazme dojke - endokrini terapija - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
copiktra
secura bio limited - duvelisib - leukemia, lymphocytic, chronic, b-cell; lymphoma, follicular - antineoplastična sredstva - copiktra monotherapy is indicated for the treatment of adult patients with: relapsed or refractory chronic lymphocytic leukaemia (cll) after at least two prior therapies. follicular lymphoma (fl) that is refractory to at least two prior systemic therapies.
topisolon mite
mazilo - dezoksimetazon
topisolon
mazilo - dezoksimetazon
topisolon
mazilo - dezoksimetazon
topisolon mite
mazilo - dezoksimetazon
tenzopril hct 30 mg/12,5 mg filmsko obložene tablete
menarini international o.l.s.a. - hidroklorotiazid; zofenopril - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta zofenopril28,7 mg / 1 tableta; zofenopril 28,7 mg / 1 tableta - zofenopril in diuretiki
tenzopril hct 30 mg/12,5 mg filmsko obložene tablete
menarini international o.l.s.a. - hidroklorotiazid; zofenopril - filmsko obložena tableta - hidroklorotiazid 12,5 mg / 1 tableta zofenopril28,7 mg / 1 tableta; zofenopril 28,7 mg / 1 tableta - zofenopril in diuretiki
olanzapin krka 2,5 mg tablete
krka, d.d., novo mesto - olanzapin - tableta - olanzapin 2,5 mg / 1 tableta - olanzapin
olanzapin krka 20 mg tablete
krka, d.d., novo mesto - olanzapin - tableta - olanzapin 20 mg / 1 tableta - olanzapin